AshaBhaskaranPillaiMD

Pediatric Hematology & Oncology • Miami, FL

Assistant Member/Professor

Join to view full profile

Dr. Pillai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pillai's full profile

Already have an account?

Office
1475 NW 12th Ave
Miami, FL 33136
Phone+1 305-243-8213

Fax+1 901-595-5918

Education & Training

Stanford Health Care2004
Stanford Health Care2004
Stanford University School of MedicineClass of 2004
Baylor College of MedicineResidency, Internal Medicine/Pediatrics, 1999
Stanford University BS, Microbiology and Immunology, 1986 - 1990

Certifications & Licensure

CA State Medical License 1999 - Present
FL State Medical License 2016 - 2024
TN State Medical License 2009 - 2016
TX State Medical License 1998 - 2000
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies Start of enrollment: 2010 Sep 01
Completed
Phase 3

Publications & Presentations

PubMed

7 citations
Turning the Tide for Academic Women in STEM: A Postpandemic Vision for Supporting Female Scientists.
Anuj S. Shah, Isabella Lopez, Bapurao Surnar, Shrita Sarkar, Lunthita Duthely
ACS Nano. 2021-12-01
19 citations
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer.
Jashodeep Datta, Anna Bianchi, Iago De Castro Silva, Nilesh U Deshpande, Long Long Cao
Oncogene. 2022-07-01
2 citations
Editorial: Innate immune cell therapy of cancer.
Natasha Khatwani, Rizwan Romee, Asha B Pillai
Frontiers in Immunology. 2022-01-01

Press Mentions

Precision Medicine Advances in Cancer Treatment Highlighted at Inaugural Sylvester ConferenceApril 12th, 2022

Grant Support

Regulatory T Cells, Mixed Chimerism: A Novel Transplant Strategy For ThalassemiasNational Heart, Lung, And Blood Institute2009–2012
Regulatory T Cells, Mixed Chimerism: A Novel Transplant Strategy For ThalassemiasNational Heart, Lung, And Blood Institute2008–2009

Other Languages

Malay